MetaCap

Labcorp Financial Ratios

NYSE: LHHealth CareMedical SpecialitiesUSD

312.15-2.05 (-0.65%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Labcorp ratio analysis

Labcorp earned a net margin of 6.3% in FY 2025, up from 5.7% a year earlier. Gross margin was 28.8% compared with a median of 29.9% over the prior 9 years. Return on equity reached 10.2%, meaning Labcorp generated 0.10 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.65 versus 0.79 the year before, and the current ratio was 1.42. At the end of FY 2025, LH traded at 24.1 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 11.0 to 47.6, with a median of 15.3. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Labcorp financial ratios (annual)

Labcorp annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2021FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)24.0625.9247.6514.4811.0711.0117.2112.7711.6016.17
Price / sales1.501.481.631.551.991.221.220.981.361.18
Price / book2.432.392.511.832.541.801.841.582.062.05
Gross margin28.8%27.9%27.7%31.3%38.0%35.4%28.1%28.0%30.0%29.9%
Operating margin9.9%8.4%6.0%12.1%23.2%17.5%11.5%11.7%12.7%13.3%
Net margin6.3%5.7%3.4%10.8%18.1%11.1%7.1%7.8%11.9%7.5%
Free cash flow margin8.6%8.4%7.2%12.9%20.5%12.5%9.0%8.2%11.5%9.6%
Return on equity (ROE)10.2%9.3%5.3%12.7%23.1%16.5%10.8%12.5%18.0%12.9%
Return on assets (ROA)4.8%4.1%2.5%6.3%11.7%7.8%4.6%5.5%7.4%5.0%
Debt / equity0.650.790.640.530.530.610.810.850.991.06
Current ratio1.421.441.171.501.921.661.121.511.251.36
Revenue growth7.2%7.0%2.5%-9.7%-6.0%21.0%2.0%9.9%7.9%10.1%
EPS growth18.3%85.3%-65.9%-42.7%53.6%90.2%-3.0%-27.1%73.2%56.8%

Related